SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Paushak Ltd (PAUSHAKLTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532742 NSE: PAUSHAKLTD Chemicals | Small Cap | Paushak Share Price

₹545.15 -11.70 (-2.10%)

As on 03-Jul'26 16:59

Paushak Ltd (PAUSHAKLTD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532742 NSE: PAUSHAKLTD Chemicals | Small Cap | Paushak Share Price

₹545.15 -11.70 (-2.10%)

As on 03-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹1,344 Cr.
Current Price
₹545.2
52-Week Low / High
₹343 / 991
TTM EPS
₹16
TTM Sales
₹219 Cr.
Book Value per Share
₹199.2
P/E Ratio
34.18
Lower than its 5-year historical median
Industry PE
52.7
Price to Book (P/B)
2.74
Lower than its 5-year historical median
Price to Sales (P/S)
6.15
Lower than its 5-year historical median
EV/EBITDA
19.48
Lower than its 5-year historical median
Dividend Yield
0.46%
Profitability Efficiency
Return on Equity (ROE)
8.22%
Underperforms industry median
Return on Capital Employed (ROCE)
9.73%
Underperforms industry median
Return on Assets (ROA)
6.38%
Operating Profit Margin
27.9%
Net Profit Margin
17.99%
Gross Profit Margin
32.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
3.63%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
1.93%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-20.35%
Asset Quality
Promoter Holding
67.28%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹479 Cr.
Equity
₹12.3 Cr.
Face Value
₹5
All Time Low / High
₹2.75 / 1550.00

Paushak stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Paushak Ltd a good quality company?
Paushak Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Paushak Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Paushak Ltd vs industry peers?
Paushak Ltd revenue CAGR is 8.87%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Paushak Ltd?
Promoters hold 67.28% of the Paushak Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Paushak Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 18.9% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Paushak Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 18.6%29.4%33.7%22.5%20.7%17.4%22%18.7%13.1%9.7%-
Value Creation
Index
0.31.11.40.60.50.30.60.3-0.1-0.3-

Growth Parameters

Sales 66.7103140138141150212206211219219
Sales YoY Gr.-55.2%34.9%-1.2%2.2%6.5%41.5%-2.9%2.3%3.6%-
Adj EPS 3812.413.114.614.820.519.717.613.716
YoY Gr.-164.9%55.3%5.5%11.1%1.6%38.4%-3.5%-10.8%-22.1%-
BVPS (₹) 32.444.17292.2110.2123.9143.5165.5188.8199.2199.2
Adj Net
Profit
7.720.530.632.335.936.550.448.743.433.839
Cash Flow from Ops. 12.410.523.545.429.84442.75637.653.7-
Debt/CF from Ops. 00.10000000.71.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 14.1%9.2%1%3.6%
Adj EPS 18.3%-1.2%-12.5%-22.1%
BVPS22.4%12.6%11.6%5.5%
Share Price 20.3% -11.9% -13.4% -10.8%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
10.220.921.11614.412.615.312.89.97.18
Op. Profit
Mgn %
18.628.428.831.135.836.235.531.428.327.927.8
Net Profit
Mgn %
11.619.82223.425.524.323.823.620.615.518
Debt to
Equity
000000000.10.20.1
Working Cap
Days
14213713913513414011813515317394
Cash Conv.
Cycle
9577807562727091868550

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales67103140138141150212206211219
Operating Expenses + 557499959196137142151158
Manufacturing Costs11151822223148465251
Material Costs25375445343046454446
Employee Cost 12141818202227303540
Other Costs 78910151317202021
Operating Profit 12294043505475646061
Operating Profit Margin (%) 18.2%28.4%28.8%31.0%35.8%36.1%35.4%31.3%28.3%27.8%
Other Income + 5335659201412
Exceptional Items 00102002000
Interest 0000000001
Depreciation 33445913141521
Profit Before Tax 14294945525072715950
Tax 37101014131817911
Profit After Tax 11213935373854544939
PAT Margin (%) 16.4%20.8%27.9%25.3%26.5%25.1%25.4%26.4%23.4%18.0%
Adjusted EPS (₹)4.38.415.814.215.115.321.922.020.016.0
Dividend Payout Ratio (%)8.80%4.50%4%5.30%5%9.80%10%11.30%12.50%15.70%

Valuation of Paushak - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 83113178227272306354408465491
Share Capital 33333333312
Reserves 80110174224269302351405462479
Debt +010000002562
Long Term Debt000000002560
Short Term Debt0100000002
Minority Interest0000000000
Trade Payables5171114111815162031
Others Liabilities 6132629464246576176
Total Liabilities 94144214270329367415481572660

Fixed Assets

Net Fixed Assets +3537384151147149152141377
Gross Block3843485571175190206210466
Accumulated Depreciation371015202841546990
CWIP 0161668872919026
Investments 3353116163154151182223139150
Inventories9121816141923222237
Trade Receivables16393226334052515555
Cash Equivalents 0011101111
Others Assets 023682242515
Total Assets 94144214270329367415481572660

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + 12102445304443563854
PBT 14294945525072715950
Adjustment -21-9-3-143-6111
Changes in Working Capital 2-13-611-8-1-204-11-2
Tax Paid -2-6-11-9-13-9-13-13-11-5
Cash Flow From Investing Activity + -11-10-0-43-29-42-38-50-57-95
Capex -6-6-10-19-56-48-15-39-160-88
Net Investments -6-510-28253-28-1698-12
Others 1113234455
Cash Flow From Financing Activity + -2-1-23-2-2-2-4-51942
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000000002550
Interest Paid -0-0-0-0-0-0-0-0-0-4
Dividend Paid -1-1-1-2-2-2-4-5-6-6
Others -10-22-000-0002
Net Cash Flow -0000-1-000-10

Financial Ratio

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)14.4321.8926.817.2514.9513.0316.3814.2711.38.22
ROCE (%)18.6329.4433.7322.4520.717.442218.6813.119.73
Asset Turnover Ratio0.820.880.780.570.470.430.540.460.40.35
PAT to CFO Conversion(x)1.090.480.621.290.811.160.81.040.781.38
Working Capital Days
Receivable Days93.709693.1077.6076.5088.3079.3091.309191.30
Inventory Days44.703639.2045.2038.9039.8035.9039.4037.6048.70
Payable Days94.20108.7095.9098.60132.70181.10134.20127.40149.50202.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Paushak Ltd FAQs

The current trading price of Paushak on 03-Jul-2026 16:59 is ₹545.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Jul-2026 the market cap of Paushak stood at ₹1,344.2 Cr

The latest P/E ratio of Paushak as of 02-Jul-2026 is 34.18.

The latest P/B ratio of Paushak as of 02-Jul-2026 is 2.74.

The 52-week high of Paushak is ₹991.2 and the 52-week low is ₹343.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Paushak is ₹219 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Paushak Ltd is a good quality company.

The key valuation ratios of Paushak Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Paushak Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Paushak Ltd

Paushak, an Alembic Group company, was established in 1972, 40 Kms outside Vadodara (Gujarat) and about 400 Kms north of Mumbai. Over the years the company has established a multi product capability in Phosgene & its derivatives manufacturing.

In last more than 25 years the experience of the company has given it an Indigenous process development capability. The company has also handled custom synthesis and contract based research.

The company offers a high degree of supply reliability for large scale products and speciality chemicals. Its production complex consists of multiple products plants that can be fine turned to run under optimal conditions for a given product.

It has been manufacturing Phosgene for mare than three decades from the basic raw materials. Paushak is producing more than 150 tons of Phosgene per month. Paushak has production capacity of 150 tons per month of phosgene with a turnover of $ 3.5 Million per annum with a workforce of 200 plus.

The company has an in-house process development and R & D laboratory. They also have corporate support in production, R&D, QA, etc.

Phosgene is a versatile molecule and its derivatives have applications in diverse fields like pharmaceuticals, agrochemicals , polyurethanes, perfumeries, dyes, etc.

Product range of the company includes:

  • Isocyanates
  • Chloroformates
  • Carbamoyl Chlorides
  • Urea & Other

Achievements/ recognition:

  • Certificate of merit for the years 1990-91 & 1991-1992 by Chemexcil (Government of India)
  • Recognized for export performance by government of Gujarat in the year 1991-1992
  • Recognized for its contribution towards environment in the year 1997 by Forest Department (State government).
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: